LATIB - effects and indications


 

passer for disse problemene:
For behandling av Philadelphia-kromosompositiv kronisk myeloid leukemi (Ph+ CML), Ph+ akutt lymfoblastisk leukemi, myelodysplastiske/myeloproliferative sykdommer, aggressiv systemisk mastocytose, hypereosinofilt syndrom og/eller kronisk eosinofil leukemi (CEL), dercoma maligne tumorer og promibromante tumorer. ( GIST).

Komplett oversikt over medikamentindikasjoner:
  • Sprengningsfase
  • Smittsomme sykdommer
  • Kongestiv hjertesvikt
  • Leukemi
  • Akutt lymfatisk leukemi
  • Myeloid leukemi, kronisk
  • Leukemi, Myeloid, Kronisk fase
  • Nøytropeni
  • Pleural effusjonsforstyrrelse
  • Nyresvikt
  • Mastocytose, systemisk
  • Gastrointestinale stromale svulster
  • Kronisk eosinofil leukemi
  • Dermatofibrosarcoma Protuberans
  • Philadelphia kromosom positiv
  • Aggressiv systemisk mastocytose
  • Hypereosinofilt syndrom


    • 

    Latib -

    Overview
    Side effects
    Interactions
    Dosage
    Prices & alternatives
    Package insert
    Package insert - complet
    Interactions (all)
    Side effects (all)
    Availability
    Effects, indications
    Alternatives
    Latib - Alcohol
    Reviews and ratings
    Rankings
    Comments
    Discussion (faq)
    Summary of data
    Summary of data - package insert (spc)


    Copyright © 2018 Pharmacum.eu. All Rights Reserved. (0.34)

    Mer informasjon